Skip to main content
14 September 2025
Last updated:
Saturday 13 September 2025
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
2012 was the year of the antibody developer
Read more
Adaptive licensing: A new approach for drug approvals
Read more
EU Transparency Directive: changes afoot on pricing and reimbursement
Read more
Encode project produces many findings
Read more
German drug policy puts pressure on prices in Europe
Read more
Advances in DNA sequencing drive medical discovery
Read more
Avastin vs Lucentis: the drug reimbursement dilemma of the century
Read more
What lies ahead for AstraZeneca
Read more
EU pharmacovigilance law comes into force
Read more
NICE exports its health technology expertise
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
18
Page
19
Page
20
Page
21
Page
22
Page
23
Current page
24
Page
25
Page
26
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form